|Day Low/High||34.25 / 35.14|
|52 Wk Low/High||21.88 / 42.64|
Cardiovascular Systems, Inc. (Nasdaq: CSII): Key financial results improved in fiscal third quarter 2010 over prior-year quarter Revenue increased 9 percent to $16.
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), has completed patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company’s 360° Clinical Series.
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2010 third-quarter conference call on Wednesday, May 5, 2010, at 3:45 p.
Sirius XM was among several stocks trading near $5 poised to move on above-average volume during Wednesday's session.
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), has received Food and Drug Administration unconditional Investigational Device Exemption (IDE) approval, allowing the company to proceed with ORBIT II, a pivotal trial ...
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), announced today that it has established a $25 million credit facility with Silicon Valley Bank and up to $4 million in convertible debt with Partners for Growth.
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2010 second-quarter conference call on Wednesday, February 3, 2010, at 3:45 p.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.